Not applicableEnded earlyNCT01029184What this trial is testingTolerance of Cereals for Atopic ChildrenWho this might be right forAllergy Société des Produits Nestlé (SPN) 45
Not applicableLooking for participantsNCT04826744What this trial is testingFrequency of Palpebral Involvement in Adult With Atopic DermatitisWho this might be right forAtopic Dermatitis University Hospital, Lille 550
Testing effectiveness (Phase 2)Study completedNCT00507832What this trial is testingEvaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic DiseaseWho this might be right forPrurigo Nodularis University Hospital Muenster 30
Large-scale testing (Phase 3)Study completedNCT03961529What this trial is testingLong-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic DermatitisWho this might be right forAtopic Dermatitis Otsuka Pharmaceutical Co., Ltd. 366
Not applicableStudy completedNCT02906475What this trial is testingAtopic Dermatitis in Atopy Predisposed InfantsWho this might be right forDermatitis, Atopic HiPP GmbH & Co. Vertrieb KG 160
Not applicableStudy completedNCT01897506What this trial is testingAssessing Risk of Food Insecurity Within Households of Children With Food AllergyWho this might be right forFood AllergyAsthmaAllergic Rhinitis+2 more Arkansas Children's Hospital Research Institute 650
Early research (Phase 1)Study completedNCT06248814What this trial is testingEvaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic DermatitisWho this might be right forDermatitis, Atopic Bristol-Myers Squibb 64
Testing effectiveness (Phase 2)Study completedNCT03921411What this trial is testingA Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)Who this might be right forAtopic Dermatitis Galderma R&D 20
Early research (Phase 1)Study completedNCT05564221What this trial is testingA Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic DiseasesWho this might be right forAtopic Healthy SubjectsAdult Subjects With Allergic Diseases Yuhan Corporation 46
Large-scale testing (Phase 3)Study completedNCT05633355What this trial is testingAssess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)Who this might be right forAtopic Dermatitis Amgen 187
Testing effectiveness (Phase 2)UnknownNCT02062476What this trial is testingEpigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk AllergyWho this might be right forCow's Milk Allergy Federico II University 20
Not applicableEnded earlyNCT01337635What this trial is testingVitamin D Deficiency and Atopic DermatitisWho this might be right forAtopic DermatitisVitamin D Deficiency Medical College of Wisconsin 7
Not applicableStudy completedNCT03632174What this trial is testingEvaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis BioGaia AB 36
Not applicableLooking for participantsNCT03936335What this trial is testingAn Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)Who this might be right forAdverse Pregnancy OutcomesAtopic Dermatitis Regeneron Pharmaceuticals 3,930
Testing effectiveness (Phase 2)Looking for participantsNCT06810050What this trial is testingPhase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic DermatitisWho this might be right forAtopic Dermatitis (AD) CAGE Bio Inc. 180
Not applicableUnknownNCT05502185What this trial is testingTargeting Staphylococci in Atopic DermatitisWho this might be right forAtopic Dermatitis L'Oreal 60
Not applicableAvailableNCT04159597What this trial is testingExpanded Access to UpadacitinibWho this might be right forCrohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+1 more AbbVie
Not applicableStudy completedNCT00820820What this trial is testingIDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic DermatitisWho this might be right forAtopic Dermatitis Institut National de la Santé Et de la Recherche Médicale, France 20
Not applicableLooking for participantsNCT06882148What this trial is testingDrug Survival of Target Therapies in Atopic DermatitisWho this might be right forAtopic Dermatitis Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,167
Large-scale testing (Phase 3)Study completedNCT04845620What this trial is testingTrial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)Who this might be right forAtopic Dermatitis Eczema Arcutis Biotherapeutics, Inc. 652